The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 17, 2024

Filed:

May. 18, 2018
Applicant:

The Children's Medical Center Corporation, Boston, MA (US);

Inventors:

Fan Zhang, Chestnut Hill, MA (US);

Richard Malley, Beverly, MA (US);

Yingjie Lu, Chestnut Hill, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/04 (2006.01); A61P 31/06 (2006.01); C07K 14/35 (2006.01); C07K 14/465 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/04 (2013.01); A61P 31/06 (2018.01); C07K 14/35 (2013.01); C07K 14/465 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55 (2013.01); A61K 2039/552 (2013.01); A61K 2039/6087 (2013.01); A61K 2039/625 (2013.01); A61K 2039/70 (2013.01); C07K 2319/40 (2013.01);
Abstract

The present embodiments provide for a() Multiple Antigen Presenting System (MAPS) immunogenic composition comprising an immunogenic polysaccharide which induces an immune response, where at least onepeptide or polypeptide antigen is associated to the immunogenic polysaccharide by complementary affinity molecules. In some embodiments, the immunogenic polysaccharide can be an antigenic capsular polysaccharide of a, Type 5 (CP5) or Type 8 (CP8), or a combination of Type 5 or Type 8 capsular polysaccharide from, or alternatively, a different immunogenic capsular or noncapsular polysaccharide, and where the protein or peptideantigens are indirectly linked via an affinity binding pair. The present-MAPS immunogenic compositions can elicit both humoral and cellular immune responses to the immunogenic polysaccharide and one or multipleantigens at the same time.


Find Patent Forward Citations

Loading…